To demonstrate a direct interaction between activating kinases and NHE1, co-immunoprecipitation was performed in MV4-11, characterized by FLT3-ITD, the most common activating kinase mutation in AML. This evidence concerns the gene SLC9A1 and acute myeloid leukemia.